Precision Medicine

Circulating Tumor Cells, a marker for research labs and CLIA labs for personalized treatment strategy and follow-up :

  • A combined system for blood sample preparation
    & automated CTCs detection.
  • PathoScan CTC reader analyzer is adapted to several CTC
    commercial  kits and others may be adapted.
  • Proven sensitivity over 99%, on thousands of samples.

Benefits

Personalized medicine

Benefits to patients treatment decision at early-stage and in advanced cancers.

Cost efficiency

Save time of conventional screening personnel by 5 folds while improving the eyes scoring technique sensitivity & specificity.

Image Gallery

PathoScan CTC
Automated detection of CTC (isolated or clustered) preparation on slide in FISH + IF staining
PathoScan CTC
Automated detection of CTC (isolated or clustered) preparation on filter with Giemsa staining

Scientific Publications

  • Cui Z et al. (2020) Circulating tumour cells as prognosis predictive markers of neoadjuvant chemotherapy-treated breast cancer patients. J of Chemotherapy. Read more
  • Li Y. et al. (2018) Improvement of sensitive and specific detection of circulating tumor cells using negative enrichment and immunostaining-FISH. Clinica Chimica Acta 485 (2018) 95–102. Read more 
  • Groult J., Homsy C., Tatarinova E., Da Meda L., Benali-Furet N., Ye F., Papine A., Uzan G., Lebbé C., Wechsler J., Soussaline F. (2018) CTCs/CTMs Automated detection after size-bazed selection from blood of patients with melanoma. 11th ISMRC, Montpellier, France, May. Read more
Back to solutions